Citius Pharmaceuticals, Inc. to Present at the Spring Investor Summit on March 25th-26th in New York City
Back to Newsroom
Mentioned in this Article

Citius Pharmaceuticals, Inc. to Present at the Spring Investor Summit on March 25th-26th in New York City

Tuesday, March 3, 2020 4:45 PM
Share this article now
Topic:
Conferences

NEW YORK, NY / ACCESSWIRE / March 3, 2020 / Citius Pharmaceuticals, Inc. (NASDAQ:CTXR), is a specialty pharmaceutical company dedicated to the development and commercialization of drug products that address important unmet medical needs, will be presenting at this year's Spring Investor Summit on March 25th-26th in New York City.

The Spring Investor Summit will take place at the Essex House, featuring 100 companies and over 500 institutional and retail investors.

About Citius Pharmaceuticals, Inc.

Citius is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives, cancer care and unique prescription products that use innovative, patented or proprietary formulations of previously approved active pharmaceutical ingredients. We seek to achieve leading market positions by providing therapeutic products that address unmet medical needs. By using previously approved drugs with substantial safety and efficacy data, we seek to reduce the risks associated with pharmaceutical product development and regulatory requirements. Citius develops products that have intellectual property protection and competitive advantages to existing therapeutic approaches.

The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors.

To register as a presenting company: please contact Cassandra Miller ([email protected])

To request complimentary investor registration: please visit our website at www.microcapconf.com

News Compliments of ACCESSWIRE

FOR MORE INFORMATION

Please visit: www.microcapconf.com

Or, contact Cassandra Miller at [email protected]

SOURCE: Citius Pharmaceuticals, Inc.

Citius Pharmaceuticals Inc
Back to Newsroom
Copyright 2021 © ACCESSWIRE. All rights reserved. Privacy Policy  |  Terms and Conditions
Drop us a line: